Top Markets
#1 OVERTAKE OVERTAKE +74.18%
#2 Clearpool Clearpool +29.60%
#3 Playnance Playnance +28.17%
#4 Concordium Concordium +23.87%
#5 Nillion Nillion +19.42%
#6 B3 (Base) B3 (Base) +18.55%
#7 deBridge deBridge +17.19%
#8 龙虾 (Lobster) 龙虾 (Lobster) +14.40%
#9 Codatta Codatta +14.22%
#10 Raydium Raydium +13.19%
Coin of the day
OVERTAKE OVERTAKE
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Rang in Aktien #23
Johnson & Johnson is a holding company, which engages in the research,... Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Aktienkurs
$266.50
Marktkapitalisierung
$642.24B
Veränderung (1 Tag)
-1.13%
Veränderung (1 Jahr)
50.92%
Land
US
Handel Johnson & Johnson (JNJ)

Kategorie

Healthcare
Aktien-Split-Historie für Johnson & Johnson (JNJ)
Die Aktie Johnson & Johnson (Symbol: JNJ) durchlief insgesamt 7 Aktiensplits.
Der letzte Aktiensplit fand am Jun 13, 2001 statt.
Eine JNJ-Aktie, die vor dem Jun 19, 1967 gekauft wurde, entspricht heute 432 JNJ-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
2001-06-13 2:1 x2 x432
1996-06-12 2:1 x2 x216
1992-06-10 2:1 x2 x108
1989-05-11 2:1 x2 x54
1981-05-19 3:1 x3 x27
1970-05-18 3:1 x3 x9
1967-06-19 3:1 x3 x3
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 4 x15
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 0 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 2 x10000
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 7 x226
US
Novartis AG Novartis AG
Novartis AG
NOVN.SW
 2 x47
CH